2008 SORBENT SYSTEM

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 05 report with the FDA on 2010-12-14 for 2008 SORBENT SYSTEM manufactured by Renal Solutions.

Event Text Entries

[1828097] A pt was being dialyzed on the 2008 sorbent system and complained of itching of their hands and feet three minutes in the treatment. The pt complained that their tongue and lips were burning. The 2008 sorbent system was placed in "pause" mode. The physician was present and instructed the pt care tech to rinse back the pt's blood and thus cease the dialysis treatment. The pt continued to complain of burning in their throat, then nausea. It was noted that the pt's eyes, lips, and face had some swelling. The pt's blood pressure at the time was 57/33, an ekg reported sinus tachycardia of 147 bpm. Blood pressure had been 126/92, and heart rate 85/min just before start of dialysis. A 50mg of diphenhydramine was given ivp and the pt was placed on o2 at 2l/min. The pt was alert and oriented throughout the incident. The pt was placed on a single pass system and dialyzed as per their usual dialysis treatment. The pt was observed during dialysis by the physician. At the end of the dialysis treatment, vital signs had returned to normal and aside from slight edema of the pt's eyes and the pt's symptoms had subsided. The pt was discharged home. After the pt was taken off of the device, it was concluded that the pt had idiosyncratic reaction to the dialysis procedure as evidence by itchiness, facial swelling and tachycardia. The pt also showed signs of hypertension which ensued after iv benadryl was provided. No permanent sequelae of the incident was observed. The analysis of the laboratory data obtained during this sequence of events indicated hemoconcentration, as evidence by a rise of hematocrit from 30% pre-treatment to with the sorb 2008 machine; it rose to 36% after 7 minutes into treatment and subsequently rose to 42%. The last observed hematocrit was at the end of treatment was 40% and levels of histamine, ige, c3, and c4 were normal.
Patient Sequence No: 1, Text Type: D, B5


[8822097] The 2008 sorbent system was evaluated by the user facility bio-technician as they were trained to service and verify operation of the system. The 2008 sorbent system (b)(4) was evaluated and found to be operating within the expected as indicated below: operation of the device was verified one day after the incident by the user facility bio-technician; the device was setup and a mock pt treatment was run on it. The unit had no recorded issues and all of the functional parameters indicated that the 2008 sorbent system operated during the mock pt treatment as designed. The console logs from the mock pt treatment were pulled from the device and evaluated by the renal solutions.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number3005778453-2010-00001
MDR Report Key1929832
Report Source05
Date Received2010-12-14
Date of Report2010-12-09
Date of Event2010-11-10
Date Mfgr Received2010-11-10
Device Manufacturer Date2010-05-01
Date Added to Maude2011-01-25
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA0
Event Location0
Manufacturer ContactDAVID VANELLA
Manufacturer Street770 COMMONWEALTH DRIVE
Manufacturer CityWARRENDALE PA 15086
Manufacturer CountryUS
Manufacturer Postal15086
Manufacturer Phone7247202840
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand Name2008 SORBENT SYSTEM
Generic NameDIALYSATE DELIVERY, SORBENT REGENERATIVE
Product CodeFKT
Date Received2010-12-14
Model NumberNA
Catalog NumberNA
Lot NumberNA
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerRENAL SOLUTIONS
Manufacturer AddressWARRENDALE PA 15086 US 15086


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2010-12-14

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.